Zai Lab Announces the First Listing of VYVGART (efgartigimod alfa injection) and Other Updates in China's National Reimbursement Drug List Seite 1
13.12.2023 - Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2023 National Reimbursement Drug List (NRDL) released by China’s National Healthcare Security Administration (NHSA) has been updated to include the following medicines and ... Seite 1
Source: wallstreet-online.de